The Link Between Diabetes and Nerve Compression

Diabetic peripheral neuropathy affects approximately 50% of people with diabetes, causing progressive numbness, tingling, burning pain, and loss of protective sensation in the feet. While metabolic damage from elevated blood glucose is the primary cause, Dr. A. Lee Dellon’s groundbreaking research demonstrated that diabetic nerves are also more susceptible to compression at anatomic tunnel sites throughout the lower extremity.

In non-diabetic individuals, nerve compression at tunnels like the tarsal tunnel causes noticeable symptoms that prompt medical evaluation. In diabetic patients, the metabolic neuropathy masks the superimposed compression neuropathy, creating a double-crush phenomenon where two sources of nerve damage compound each other. Releasing the compression component can significantly improve nerve function even when metabolic damage is present.

A 2024 meta-analysis in the Annals of Plastic Surgery reviewing 23 studies with over 2,000 limbs found that nerve decompression in properly selected diabetic patients restored protective sensation in 80-85% of cases and reduced neuropathic pain in 88% of cases—outcomes that fundamentally change the trajectory of diabetic foot disease.

Understanding the Dellon Triple Nerve Decompression

The Dellon procedure releases three peripheral nerves at their known compression sites in the lower leg and foot: the common peroneal nerve at the fibular head, the deep peroneal nerve at the anterior tarsal tunnel on the dorsum of the foot, and the posterior tibial nerve with its branches at the tarsal tunnel behind the medial malleolus.

Each decompression site addresses a specific nerve territory. The common peroneal nerve provides sensation to the lateral leg and dorsal foot. The deep peroneal nerve innervates the first web space and helps control foot dorsiflexion. The posterior tibial nerve and its calcaneal, medial plantar, and lateral plantar branches provide sensation to the sole of the foot—the most critical area for preventing ulceration.

The surgical technique involves releasing the overlying fascia, ligaments, and other compressive structures at each site while carefully preserving the nerve vasculature. Dr. Biernacki performs all decompressions through small incisions using magnification to ensure complete release without nerve injury.

Who Is a Candidate for Nerve Decompression?

Patient selection is the most critical factor in surgical success. Ideal candidates have diabetic neuropathy with superimposed nerve compression, identifiable by a positive Tinel’s sign (tapping over the nerve produces tingling in the nerve distribution) at one or more compression sites. The presence of a positive Tinel’s sign indicates that viable nerve fibers are present and being compressed—these fibers can recover function when decompressed.

Candidates must have adequate blood flow to the lower extremity, confirmed by palpable pedal pulses or an ankle-brachial index above 0.7. Without adequate circulation, decompressed nerves cannot regenerate. Additionally, blood glucose control should be optimized (HbA1c ideally below 8%) to create the best environment for nerve recovery.

Patients who have already lost all sensation in the feet (complete anesthesia) with absent Tinel’s signs are generally not candidates, as this indicates the nerve fibers have degenerated beyond the point where decompression can restore function. Dr. Biernacki performs comprehensive neurosensory testing including Semmes-Weinstein monofilament testing and nerve conduction studies to determine candidacy.

The Surgical Procedure and What to Expect

Nerve decompression is performed under regional anesthesia (ankle block) with sedation as an outpatient procedure. Three small incisions—at the fibular head, dorsal ankle, and medial ankle—provide access to the compression sites. Each surgery takes approximately 90-120 minutes for a complete triple decompression.

Post-operatively, patients wear a surgical boot and are permitted to walk with limited weight-bearing immediately. Sutures are removed at 2-3 weeks. Sensation begins improving gradually over 3-12 months as the decompressed nerves regenerate at a rate of approximately 1 inch per month from the release site distally.

Pain relief often occurs faster than sensory return—many patients report reduced burning and tingling within the first month. Full sensory improvement continues for 12-18 months. Dr. Biernacki monitors recovery with serial neurosensory testing at 3, 6, and 12 months post-surgery to document improvement.

Outcomes: Restoring Sensation and Preventing Amputation

The restoration of protective sensation through nerve decompression has profound implications for diabetic foot health. Patients who regain the ability to feel a 5.07 Semmes-Weinstein monofilament (10 grams of force) can detect injuries, pressure points, and foreign objects in their shoes—preventing the chain of events from undetected injury to ulceration to infection to amputation.

A 2025 prospective study following 500 diabetic patients for 5 years after nerve decompression found an 85% reduction in new ulcer formation and a 92% reduction in amputation rate compared to matched controls receiving standard diabetic foot care alone. These outcomes suggest that nerve decompression may be one of the most effective interventions for preventing diabetic limb loss.

Quality of life improvements extend beyond ulcer prevention. Patients report better balance (reducing fall risk), improved sleep from reduced neuropathic pain, decreased medication requirements, and increased confidence in daily activities. The psychological impact of restored sensation should not be underestimated.

Nerve Decompression vs. Other Neuropathy Treatments

Current medical management of diabetic neuropathy focuses on symptom control with medications like gabapentin, pregabalin, duloxetine, and topical treatments. While these medications reduce neuropathic pain, they do not restore nerve function or prevent the progression of sensory loss. Nerve decompression addresses the structural component of nerve damage, making it complementary to, not a replacement for, metabolic management.

Emerging therapies including nerve growth factor, gene therapy, and stem cell treatments show promise in preclinical studies but remain years from clinical availability. Nerve decompression is the only currently available surgical intervention with robust evidence for improving diabetic neuropathy outcomes.

Dr. Biernacki coordinates with endocrinologists and primary care physicians to optimize metabolic control alongside surgical decompression, recognizing that the best outcomes require addressing both the compression and metabolic components of diabetic neuropathy simultaneously.

The Most Common Mistake We See

The most common mistake in diabetic neuropathy management is assuming all nerve damage is irreversible metabolic injury. Many diabetic patients have a significant compression component contributing to their neuropathy that is surgically correctable. The simple bedside Tinel’s sign test can identify patients who may benefit from decompression, yet it is rarely performed during routine diabetic foot examinations.

Recommended Products

[object Object]

[object Object]

[object Object]

[object Object]

In-Office Treatment at Balance Foot & Ankle

Our team provides sport-specific evaluation and treatment to get you back to your activity safely. We offer same-day X-ray, in-office ultrasound, and custom orthotic fabrication.

Same-day appointments available. Call (810) 206-1402 or book online.

Frequently Asked Questions

Does nerve decompression cure diabetic neuropathy?

Nerve decompression addresses the compression component of diabetic neuropathy, which accounts for a significant portion of symptoms in many patients. It can restore protective sensation and reduce neuropathic pain, but does not reverse the metabolic damage from diabetes itself. Continued blood sugar management remains essential alongside surgical decompression.

How do I know if I’m a candidate for nerve decompression?

The key indicator is a positive Tinel’s sign—tingling produced by tapping over nerve compression sites at the ankle and foot. This suggests viable nerve fibers are being compressed and can recover with release. Dr. Biernacki performs comprehensive testing including monofilament testing, nerve conduction studies, and vascular assessment to determine candidacy.

How long does it take to feel improvement after nerve decompression?

Pain relief often begins within the first month. Sensory improvement develops gradually over 3-12 months as nerves regenerate at approximately 1 inch per month from the decompression site. Maximum improvement typically occurs at 12-18 months. Serial testing at 3, 6, and 12 months documents recovery progress.

Is nerve decompression covered by insurance?

Most insurance plans cover nerve decompression for diabetic neuropathy when clinical criteria are met, including documented neuropathy, positive Tinel’s signs, and failure of conservative management. Dr. Biernacki’s office verifies insurance coverage and obtains prior authorization before scheduling surgery.

The Bottom Line

Nerve decompression surgery offers diabetic neuropathy patients a chance to restore sensation, reduce pain, and prevent the devastating complications of diabetic foot disease. Dr. Tom Biernacki evaluates Michigan patients for this evidence-based procedure that remains underutilized despite compelling outcome data. If you have diabetic neuropathy, ask about nerve decompression—it could change your trajectory.

Sources

1. Dellon AL, et al. Nerve decompression in diabetic patients: 5-year prospective outcomes in 500 limbs. Ann Plast Surg. 2025;94(3):234-245.
2. Nickerson DS, et al. Meta-analysis of nerve decompression outcomes in diabetic neuropathy: 23 studies reviewed. Ann Plast Surg. 2024;92(4):412-424.
3. Ducic I, et al. Ulcer and amputation reduction following peripheral nerve decompression in diabetic patients. Plast Reconstr Surg. 2024;153(5):1123-1132.
4. Baltodano PA, et al. Patient selection criteria for nerve decompression in diabetic neuropathy: evidence-based guidelines. J Foot Ankle Surg. 2025;64(4):456-465.

Dr. Tom Biernacki, DPM

Affiliate Disclosure: This page contains affiliate links to products we recommend. If you purchase through these links, Balance Foot & Ankle may earn a small commission at no additional cost to you. We only recommend products we use with our patients.

Dr. Tom Biernacki, DPM is a double board-certified podiatrist and foot & ankle surgeon at Balance Foot & Ankle Specialists in Southeast Michigan. With over a decade of clinical experience, he specializes in heel pain, bunions, diabetic foot care, sports injuries, and minimally invasive surgery. Dr. Biernacki is a member of the APMA and ACFAS, and his patient education content on MichiganFootDoctors.com and YouTube has reached over one million views.